联环药业(600513.SH)：苯磺酸氨氯地平片完成药品注册

Core Viewpoint - The company has received approval from the National Medical Products Administration for its drug, Amlodipine Besylate Tablets, which is commonly used to regulate vascular pressure [1] Company Summary - The company's subsidiary, Xinxiang Changle Pharmaceutical Co., Ltd., has been granted a drug registration certificate for Amlodipine Besylate Tablets [1] - Amlodipine Besylate Tablets are recognized as a standard medication for managing blood vessel pressure [1]